Hippocampal metabolites and memory performances in patients with amnestic mild cognitive impairment and Alzheimer's disease

Neurobiology of Learning and Memory

Volumn 97, Issue 3, 2012, Pages 289-293

  Watanabe, Toshiyuki ^a,b   Shiino, Akihiko ^b   Akiguchi, Ichiro ^a,c  

^a Ujitakeda Hospital   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Center for Cerebrovascular Disease   (Japan)

Author keywords

Alzheimer's disease; Amnestic mild cognitive impairment; Myo inositol; N acetylaspartate; Proton magnetic resonance spectroscopy; Wechsler memory scale revised

Indexed keywords

INOSITOL; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; AMNESTIC MILD COGNITIVE IMPAIRMENT; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEMORY; METABOLITE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CINGULATE; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECTROSCOPY; VERBAL MEMORY; VISUAL MEMORY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMNESIA; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS;

EID: 84862828401     PISSN: 10747427     EISSN: 10959564     Source Type: Journal    
DOI: 10.1016/j.nlm.2012.01.006     Document Type: Article

References (31)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Berlin: Springer.
2. Bonferoni, C. E. (1936). Il calco delle assicurazioni su gruppi di teste. In Studi in Onore del Professore Salvatore Ortu Carboni (pp. 13-60). Rome [in Italian].
3. Chantal S., Labelle M., Bouchard R.W., Braun C.M.J., Boulanger Y. Correlation of regional proton magnetic resonabce spectroscopic changes with cognitive deficits in mild Alzheimer disease. Archives of Neurology 2002, 59:955-962.
4. Diana R.A., Van den Boom W., Yonelinas A.P. Ranganath. ERP correlates of source memory: Unitized source information increases familiarity-based retrieval. Brain Research 2011, 1367:278-286.
5. Diana R.A., Yonelinas A.P., Ranganath Medial temporal lobe activity during source retrieval reflects information type, not memory strength. Journal of Cognitive Neuroscience 2010, 22:1808-1818.
6. Fisher S.K., Novak J.E., Agronoff B.E. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. Journal of Neurochemistry 2002, 82:736-754.
7. Folstein M.F., Folstein S.N., McHugh P.R. Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
8. Grundman M., Petersen R.C., Ferris S.H., Thomas R.G., Alsen P.S., Bennet D.A., et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Archives of Neurology 2004, 61:59-66.
9. Hawkes C.H., Deng L.H., Shaw J.E., Nitz M., McLaurin J. Small molecule β-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer's disease. European Journal of Neuroscience 2010, 31:203-213.
10. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944.
11. McLaurin J., Golomb R., Jurewicz A., Antel P.J., Fraser P.E. Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid β peptide and inhibit a-induced toxicity. Journal of Biological Chemistry 2000, 275:18495-18502.
12. Moffett J.R., Ross B., Arun P., Madhavarao C.N., Namboodiri A.M.A. N-acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Progress in Neurobiology 2007, 81:89-131.
13. Mohs R.C. Administration and scoring manual for the Alzheimer's disease assessment scale 1994, The Mount Sinai School of Medicine. revised edition.
14. Morris J.C. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993, 43:2412-2414.
15. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 1998, 316:1236-1238.
16. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 1993, 30:672-679.
17. Rami L., Anson B.G., Bosch B., Sanchez-Valle R., Monte G.C., Villar A., et al. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2007, 24:274-279.
18. Ranganath C. A unified framework for the functional organization of the medial temporal lobes and phenomenology of episodic memory. Hippocampus 2010, 20:1263-1290.
19. Ross A.J., Sachdev P.S. Magnetic resonance spectroscopy in cognitive research. Brain Research Reviews 2004, 44:83-102.
20. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
21. Sallowway S., Sperling R., Keren R., Porsteinsson A.P., van Dyck C.H., Tariot P.N., et al. A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease. Neurology 2011, 77:1253-1262.
22. Shinagawa F., Kobayashi S., Fujita K., Maekawa H. Japanese wechsler adult intelligence scale-revised 1990, Nihon Bunka Kagakusha, Tokyo, [in Japanese].
23. Storandt M., Grant E.A., Miller J.P., Morris J.C. Longitudinal course and neuropathologic outcomes in original vs revised MCI and pre-MCI. Neurology 2006, 67:467-473.
24. Sugishita M. Japanese wechsler memory scale-revised 2001, Nihon Bunka Kagakusha, Tokyo, [in Japanese].
25. Valenzuela M.J., Sachdev P. Magnetic resonance spectroscopy in Alzheimer's disease. Neurology 2001, 56:592-598.
26. Vanssay-Maigne A.D., Noulhiane M., Devauchelle A.D., Rodrigo S., Baudoin-Chial S., Medeer J.F., et al. NeuroImage 2011, 58:1131-1138.
27. Watanabe T., Shiino A., Akiguchi I. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease. Dementia and Geriatric Cognitive Disorders 2008, 26:89-100.
28. Watanabe T., Shiino A., Akiguchi I. Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnestic mild cognitive impairment from Alzheimer's disease and healthy aging. Dementia and Geriatric Cognitive Disorders 2010, 30:71-77.
29. Wechsler D. Wechsler adult intelligence scale-revised 1981, The Psychological Corporation, New York.
30. Wechsler D. Wechsler memory scale-revised 1987, The Psychological Corporation, New York.
31. Yonelinas A.P., Aly M., Wang W.C., Koen J. Recollection and familiarity: Examining controversial assumptions and new directions. Hippocampus 2010, 20:1178-1194.